[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Abbott Laboratories' Q2 2026 Earnings: What to Expect

With a market cap of $162.4 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and markets a wide range of pharmaceutical, diagnostic, nutritional, and medical device products worldwide. It operates through four business segments: Established Pharmaceuticals; Diagnostics; Nutrition; and Medical Devices, serving diverse healthcare needs across the globe.

The Abbott Park, Illinois-based company is expected to unveil its fiscal Q2 2026 results before the market opens on Thursday, Jul. 16. Ahead of the event, analysts forecast ABT to post an adjusted EPS of $1.28, a rise of 1.6% from $1.26 in the same quarter last year....

Fundamentals

See More
  • Market Capitalization, $K 163,939,440
  • Shares Outstanding, K 1,741,813
  • Annual Sales, $ 44,328 M
  • Annual Income, $ 6,524 M
  • EBIT $ 9,389 M
  • EBITDA $ 12,505 M
  • 60-Month Beta 0.63
  • Price/Sales 3.66
  • Price/Cash Flow 13.34
  • Price/Book 3.08

Options Overview Details

View History
  • Implied Volatility 33.53% (+0.01%)
  • Historical Volatility 26.43%
  • IV Percentile 97%
  • IV Rank 82.98%
  • IV High 36.92% on 06/11/26
  • IV Low 16.97% on 08/12/25
  • Expected Move (DTE 4) 2.39 (2.54%)
  • Put/Call Vol Ratio 0.26
  • Today's Volume 14,918
  • Volume Avg (30-Day) 16,968
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 232,183
  • Open Int (30-Day) 254,730
  • Expected Range 91.73 to 96.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.28
  • Number of Estimates 7
  • High Estimate $1.28
  • Low Estimate $1.27
  • Prior Year $1.26
  • Growth Rate Est. (year over year) +1.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.96 +10.78%
on 05/27/26
95.21 -1.14%
on 06/26/26
+7.45 (+8.60%)
since 05/26/26
3-Month
81.97 +14.82%
on 05/11/26
105.46 -10.75%
on 03/27/26
-10.45 (-9.99%)
since 03/26/26
52-Week
81.97 +14.82%
on 05/11/26
137.49 -31.54%
on 09/22/25
-39.55 (-29.59%)
since 06/26/25

Most Recent Stories

More News
Abbott Laboratories' Q2 2026 Earnings: What to Expect

Abbott Laboratories is scheduled to report its second-quarter results in July, and analysts expect a single-digit earnings rise.

ABT : 94.12 (+0.94%)
XLV : 160.34 (+3.03%)
$SPX : 7,354.02 (-0.05%)
Abbott hosts conference call for second-quarter earnings

ABBOTT PARK, Ill. , June 25, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2026 financial results on Thursday, July 16, before the market opens.

ABT : 94.12 (+0.94%)
ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer's Diagnosis at Global Scale

ABT : 94.12 (+0.94%)
New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

ABBOTT PARK, Ill. , June 22, 2026 /PRNewswire/ -- Parenthood is widely anticipated as one of life's most fulfilling journeys, yet for today's new parents – especially Gen Z – that excitement...

ABT : 94.12 (+0.94%)
Is STERIS Stock Underperforming the Dow?

While STERIS has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

ABT : 94.12 (+0.94%)
STE : 215.67 (+2.41%)
$DOWI : 51,876.11 (-0.09%)
Abbott declares 410th consecutive quarterly dividend

ABBOTT PARK, Ill. , June 12, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.

ABT : 94.12 (+0.94%)
When Investors Finally Get Sick of AI Stocks, This Medical Devices ETF Could Be a Long-Term Winner

Over the long term, the IHI ETF looks like a good turnaround story.

ABT : 94.12 (+0.94%)
SYK : 332.71 (+5.25%)
IHI : 51.03 (+1.75%)
ISRG : 404.70 (+1.25%)
New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

NEW ORLEANS , June 8, 2026 /PRNewswire/ -- New research presented at the American Diabetes Association's 86 th Scientific Sessions showed that adults living with type 2 diabetes participating...

ABT : 94.12 (+0.94%)
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

ABBOTT PARK, Ill. , June 6, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced new data revealing diabetic ketoacidosis (DKA) remains an important, yet often undetected...

ABT : 94.12 (+0.94%)
Is Abbott Laboratories Stock Underperforming the Dow?

Abbott Laboratories has trailed the Dow Jones Industrial Average over the past year, but analysts remain highly optimistic about the company's long-term growth prospects.

ABT : 94.12 (+0.94%)
BSX : 44.23 (+0.07%)
$DOWI : 51,876.11 (-0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 97.15
2nd Resistance Point 96.18
1st Resistance Point 95.15
Last Price 94.12
1st Support Level 93.15
2nd Support Level 92.18
3rd Support Level 91.15

See More

52-Week High 137.49
Fibonacci 61.8% 116.28
Fibonacci 50% 109.73
Fibonacci 38.2% 103.18
Last Price 94.12
52-Week Low 81.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.